Sign In
Buy CYTK
$80.01
+0.84 (+1.06%)
At Close: Jun 23, 2026
Cytokinetics Announces Changes to Board of Directors
11:30am, Friday, 08'th Apr 2022 GlobeNewswire Inc.
L. Patrick Gage, Ph.D. to Retire from Board
Cytokinetics to Participate in the 21st Annual Needham Virtual Healthcare Conference
08:00pm, Wednesday, 06'th Apr 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to
Cytokinetics Announces Results From METEORIC-HF and Additional Data From GALACTIC-HF Presented at the American College of Cardiology 71st Annual Scientific Session
01:45pm, Sunday, 03'rd Apr 2022 GlobeNewswire Inc.
No Effect of Omecamtiv Mecarbil On Exercise Capacity in Patients with Heart Failure with Reduced Ejection Fraction in METEORIC-HF
Cytokinetics Announces Results From Cohort 3 of Redwood-HCM Presented at American College of Cardiology 71st Annual Scientific Session
03:30pm, Saturday, 02'nd Apr 2022 GlobeNewswire Inc.
Aficamten Reduced LVOT Gradients and Improved NYHA Class and NT-proBNP in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Disopyramide Aficamten Reduced LVOT Gradients and Improved
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:00pm, Friday, 01'st Apr 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2022 it granted stock options to purchase an aggregate of
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 71st Annual Scientific Session & Expo
08:00pm, Thursday, 24'th Mar 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced four presentations at the American College of Cardiology 71st Annual Scienti
Cytokinetics (CYTK) Investor Presentation - Slideshow
05:21pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Cytokinetics Incorporated (NASDAQ: CYTK) Shares Are Set To Rise By 2022
02:00pm, Saturday, 12'th Mar 2022 Stocks Register
Cytokinetics Incorporated (NASDAQ:CYTK) shares, rose in value on Friday, 03/11/22, with the stock price down by -0.98% to the previous day’s close as strong demand from buyers drove the stock to $37.50. Actively observing the price movement in the last trading, the stock closed the session at $37.87, falling within a range of $37.08 and … Cytokinetics Incorporated (NASDAQ: CYTK) Shares Are Set To Rise By 2022 Read More »
Cytokinetics to Participate in Upcoming Investor Conferences
09:00pm, Tuesday, 08'th Mar 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to
Cytokinetics to Participate in Upcoming Investor Conferences
09:00pm, Tuesday, 08'th Mar 2022 GlobeNewswire
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the virtual Oppenheimer 32 nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 11:20 am ET and participate in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 16, 2022 at 11:45 am ET at the Loews Miami Beach Hotel in Miami Beach.
Cytokinetics to Participate in Upcoming Investor Conferences
04:00pm, Tuesday, 08'th Mar 2022
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to pr
Cytokinetics Announces Cohort 4 of REDWOOD-HCM Is Open to Enrollment
12:30pm, Wednesday, 02'nd Mar 2022 GlobeNewswire Inc.
Cohort 4 to Enroll Patients with Non-Obstructive Hypertrophic Cardiomyopathy Cohort 4 to Enroll Patients with Non-Obstructive Hypertrophic Cardiomyopathy
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
09:00pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on February 28, 2022 it granted stock options to purchase an aggregate
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
12:30pm, Monday, 28'th Feb 2022 GlobeNewswire Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is joining the European Organisation for Rare Diseases (EURORDIS) an
